Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Capricor Therapeutics Inc., 3 years.
Capricor Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Capricor Therapeutics Inc. June 4, 202681.0%
-
Capricor Therapeutics Inc. May 22, 202596.4%
-
Capricor Therapeutics Inc. May 14, 202480.6%
-
Capricor Therapeutics Inc. June 12, 202370.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2024 | Capricor Therapeutics Inc. | Option exercise | +34,000 | $1.39 | $47,260 |
| Apr 23, 2024 | Capricor Therapeutics Inc. | Option exercise | +16,156 | $1.39 | $22,457 |
| Oct 12, 2023 | Capricor Therapeutics Inc. | Open-market purchase | +410 | $2.75 | $1,128 |
| Oct 9, 2023 | Capricor Therapeutics Inc. | Open-market purchase | +5,083 | $2.82 | $14,334 |
| Oct 4, 2023 | Capricor Therapeutics Inc. | Open-market purchase | +2,500 | $2.90 | $7,250 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.